Unknown

Dataset Information

0

Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease.

ABSTRACT: Based on previous large-scale in silico screening several factor Xa inhibitors were proposed to potentially inhibit SARS-CoV-2 Mpro. In addition to their known anticoagulants activity this potential inhibition could have an additional therapeutic effect on patients with COVID-19 disease. In this study we examined the binding of the Apixaban, Betrixaban and Rivaroxaban to the SARS-CoV-2 Mpro with the use of the MicroScale Thermophoresis technique. Our results indicate that the experimentally measured binding affinity is weak and the therapeutic effect due to the SARS-CoV-2 Mpro inhibition is rather negligible.

SUBMITTER: Papaj K 

PROVIDER: S-EPMC8752003 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro).
| S-EPMC7409236 | biostudies-literature
Unknown Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation.
| S-EPMC7903152 | biostudies-literature
Unknown De Novo design of potential inhibitors against SARS-CoV-2 Mpro.
| S-EPMC9197785 | biostudies-literature
Unknown Potential SARS-CoV-2 main protease inhibitors.
| S-EPMC7724992 | biostudies-literature
Unknown Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro.
| S-EPMC8621115 | biostudies-literature
Unknown Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design.
| S-EPMC8659229 | biostudies-literature
Unknown Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease.
| S-EPMC7664330 | biostudies-literature
Unknown Identification of bioactive molecules from <i>Triphala</i> (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations.
| S-EPMC8744360 | biostudies-literature
Unknown Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp).
| S-EPMC7534957 | biostudies-literature
Unknown Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.
| S-EPMC7698687 | biostudies-literature